R.I. to resume administration of J&J COVID-19 vaccine

RHODE ISLAND is resuming administration of the single-dose Johnson & Johnson COVID-19 vaccine. Distribution of the vaccine was paused after reports of a rare but severe side effect that triggered federal review. / COURTESY JOHNSON & JOHNSON/CHERYL GERBER
PROVIDENCE – Rhode Island will resume the administration of the Johnson & Johnson COVID-19 vaccine, the R.I. Department of Health announced Monday evening. The move follows a recommendation by the U.S. Food and Drug Administration that the temporary pause on the vaccine be lifted. The pause was initiated on April 13 following reports that six…

Thanks for reading Providence Business News. Create your free account or log in to continue reading.

Register Now Already a Subscriber? Login now


If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

- Advertisement -

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display